Medidek Pharmaceuticals Llp

Medidek Pharmaceuticals Llp - paper in Nagpur, Maharashtra, India. FY 2026 financials and compliance.
LLPIN ACD-1677 Incorporated 25 September 2023 ROC Nagpur HQ Nagpur, Maharashtra, India
Active Limited Liability Partnership paper
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Contribution obligation
₹1 Lakh
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
None
Secured borrowings
Company age
3 yrs
Est. 2023
Employees · EPFO
-
Latest available

About Medidek Pharmaceuticals Llp

Data last updated: 05 March 2026

Medidek Pharmaceuticals Llp is a limited liability partnership company based in Nagpur, Maharashtra, India. It specialises in manufacturing, a part of the broader paper and packaging sector. Incorporated on 25 September 2023.

Registered with ROC Nagpur under LLPIN ACD-1677.

Capital: a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Nihal Ahmed Mustak Patni and Fahim Yusuf Ameen.

Office: Nagpur, Maharashtra.

Company Details of Medidek Pharmaceuticals Llp
LLPIN ACD-1677
Incorporation Date 25 September 2023
Total Obligation of Contribution ₹1 Lakh
ROC Nagpur
Company Status Active
Key People
Nihal Ahmed Mustak Patni Designated Partner Fahim Yusuf Ameen Designated Partner Anand Durjan Bankar Designated Partner
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Ginger Square S No S – 50, Main Bus Stop Road, Nagpur, Maharashtra, India – 440014
  • Industry
    Paper, Manufacturing, Paper & Paper Products
Company report
Medidek Pharmaceuticals Llp - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Medidek Pharmaceuticals Llp report

Financials, compliance, directors, charges, ownership and filings for Medidek Pharmaceuticals Llp in one report.

10-year financials Directors & ownership Charges & compliance

Designated Partners of Medidek Pharmaceuticals Llp

Medidek Pharmaceuticals Llp is governed by 3 designated partners who oversee the company's operations and strategic decisions.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Nihal Ahmed Mustak Patni
Also directs: Medidek Healthcare Private Limited
Designated Partner 25 Sep 2023 2 Years 9 Months Current
Fahim Yusuf Ameen Designated Partner 25 Sep 2023 2 Years 9 Months Current
Anand Durjan Bankar
Also directs: Chakhna Food And Retail Llp, Projex Infraventure Llp, Afterlife Science Private Limited and 2 more
Designated Partner 25 Sep 2023 2 Years 9 Months Current
View all designated partners

Financials of Medidek Pharmaceuticals Llp

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****
Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings Medidek Pharmaceuticals Llp

Medidek Pharmaceuticals Llp does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Medidek Pharmaceuticals Llp

View historical data on people associated with Medidek Pharmaceuticals Llp, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Medidek Pharmaceuticals Llp

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Medidek Pharmaceuticals Llp

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Medidek Pharmaceuticals Llp

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Medidek Pharmaceuticals Llp

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Medidek Pharmaceuticals Llp

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Medidek Pharmaceuticals Llp

MSME Payment Delays by Medidek Pharmaceuticals Llp

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Medidek Pharmaceuticals Llp

Subsidiaries & Group Companies of Medidek Pharmaceuticals Llp

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Medidek Pharmaceuticals Llp with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Medidek Pharmaceuticals Llp

MCA Filings & Documents of Medidek Pharmaceuticals Llp

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Medidek Pharmaceuticals Llp

Directors
25 Sep 2023
Nihal Ahmed Mustak Patni was appointed as a Designated Partner on 25 Sep 2023 & has been associated with this company since 2 years 9 months.
Directors
25 Sep 2023
Fahim Yusuf Ameen was appointed as a Designated Partner on 25 Sep 2023 & has been associated with this company since 2 years 9 months.
Directors
25 Sep 2023
Anand Durjan Bankar was appointed as a Designated Partner on 25 Sep 2023 & has been associated with this company since 2 years 9 months.
Activity
25 Sep 2023
Medidek Pharmaceuticals Llp was registered on 25 Sep 2023 with Roc Nagpur & aged 2 years 9 months as per MCA records.

Frequently Asked Questions about Medidek Pharmaceuticals Llp

Medidek Pharmaceuticals Llp is an active limited liability partnership in the paper sector based in Nagpur, Maharashtra, India. It was incorporated on 25 September 2023 (3+ years old) and is registered under LLPIN ACD-1677.

The current designated partners of Medidek Pharmaceuticals Llp are:

The primary industry of Medidek Pharmaceuticals Llp is paper. The LLP specifically operates in manufacturing. The LLP is currently active in this sector.

Medidek Pharmaceuticals Llp can be reached at the registered office: Ginger Square S No S – 50, Main Bus Stop Road, Nagpur, Maharashtra, India – 440014.

The total obligation of contribution is ₹1 Lakh.

The LLP has its registered office at Ginger Square S No S – 50, Main Bus Stop Road, Nagpur, Maharashtra, India – 440014.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available